Analysts Calculate Fair Values For Multiple European Industrial Stocks

Recent analyses using the two-stage Discounted Cash Flow (DCF) model estimate the intrinsic values of several European companies, indicating that their current share prices are close to or slightly below fair value. EMS-CHEMIE HOLDING's stock trades near its CHF559 fair value estimate, with an analyst price target 19% higher. MedNation AG's share price aligns with its €3.82 fair value, while its competitors trade at greater discounts. LANXESS Aktiengesellschaft is valued at approximately €25.10, slightly above its current €21.06 share price, with analyst targets slightly lower than the fair value estimate. Medartis Holding AG appears fairly valued around CHF78.35, with analyst price targets about 18% higher. Separately, medondo holding AG is approaching profitability, with analysts predicting breakeven by 2026, though the company carries a relatively high debt level, posing investment risks. These valuations incorporate assumptions that companies' free cash flow growth rates will slow over time, reflecting typical business cycles and the time value of money.